89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,494,522 | -24.4% | 4,306,640 | -7.2% | 0.00% | -20.0% |
| Q2 2023 | $87,988,469 | +88.2% | 4,643,191 | +51.2% | 0.01% | +66.7% |
| Q1 2023 | $46,761,796 | +1649.0% | 3,070,374 | +1361.9% | 0.00% | – |
| Q4 2022 | $2,673,554 | +634.5% | 210,020 | +233.8% | 0.00% | – |
| Q3 2022 | $364,000 | +267.7% | 62,910 | +104.2% | 0.00% | – |
| Q2 2022 | $99,000 | -82.3% | 30,810 | -79.3% | 0.00% | – |
| Q1 2022 | $560,000 | -70.8% | 148,630 | +1.2% | 0.00% | – |
| Q4 2021 | $1,919,000 | -33.6% | 146,824 | -0.4% | 0.00% | – |
| Q3 2021 | $2,888,000 | +4.1% | 147,403 | -0.6% | 0.00% | – |
| Q2 2021 | $2,774,000 | -3.8% | 148,328 | +21.8% | 0.00% | – |
| Q1 2021 | $2,883,000 | -2.8% | 121,748 | +0.1% | 0.00% | – |
| Q4 2020 | $2,965,000 | +37.7% | 121,672 | +44.9% | 0.00% | – |
| Q3 2020 | $2,154,000 | +108.5% | 83,960 | +62.0% | 0.00% | – |
| Q2 2020 | $1,033,000 | -14.9% | 51,834 | +7.8% | 0.00% | – |
| Q1 2020 | $1,214,000 | +121.1% | 48,086 | +130.5% | 0.00% | – |
| Q4 2019 | $549,000 | – | 20,864 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |